T. Rowe Price Investment Management, Inc.
Position in APLS — Apellis Pharmaceuticals, Inc.
CIK 1897612
BALTIMORE, MD
Position in APLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
5,162
+161.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $12,244,164,567 across 51 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
6,754,846 | $1,801,652,525 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,642,173 | $1,698,463,338 | |
| 3 | CYTK |
Cytokinetics Inc
|
18,718,498 | $1,594,628,844 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
6,257,261 | $717,520,118 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
12,207,450 | $709,619,068 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
30,912,287 | $686,561,894 | |
| 7 | CGON |
CG Oncology, Inc.
|
6,616,899 | $470,130,673 | |
| 8 | IMNM |
Immunome Inc.
|
19,676,883 | $416,953,150 |
All Filings in APLS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 5,162 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 1,974 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | — | 48,756 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | — | 49,308 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | — | 47,713 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | — | 47,713 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | — | 2,985,272 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | — | 4,048,412 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | — | 4,605,721 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | — | 6,303,584 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | — | 6,519,471 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | — | 5,638,875 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | — | 5,760,664 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | — | 5,842,660 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | — | 5,516,123 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||